Drug Information

Updated On: 27-02-2024

Home

About Us

FAQs

Feedback

Disclaimer

Site Map

Home > Search > > Drug Information

Ipratropium bromide - @ Anticholinergics- (FDC- List )- (Nov 1992)

Drug Name:
Ipratropium bromide - @ Anticholinergics- (FDC- List )- (Nov 1992)

List Of Brands:

IPRATOP
IPRAVENT

Indication Type Description:

Drug Interaction

Indication

Adverse Reaction

Contra-Indications

Dosages/ Overdosage Etc

Patient Information

Pharmacology/ Pharmacokinetics

Pregnancy and lactation

Drug Interaction:

Effects are additive with adrenergic drugs. Increased toxicity with other anticholinergic drugs

Indication:

Chronic obstructive pulmonary disease.

Approved by (DCI) Drug Controller GENERAL - India For Marketing

(Ref- IDMA Publication)

Name of Drug Indication Date of Approval

Ipratropium bromide Anti-cholinergic November 1992

bronchdilator

FIXED DOSE COMBINATIONS APPROVED BY DCG(I)

FROM JANUARY 1961 TILL NOVEMBER 2014

Name of Drug Indication Date of Approval

Ipratropium Bromide 500mg + 03-04-2001

Salbutamol Sulphate

eq.to Salbutamol 2.5mg per 2.5ml respiratory

solution

For Bronchospasm in patients suffering from

Chronic Pulmonary disorders

Patent Expiry Date of drugs (Ref - IDMA Publication)

Chemical Category Manufacturer/ US Patent

Ingredient- Marketer Expiration Date

Ipratropium Respiratory Boehringer 09-06-2015

bromide & ingelheim

salbutamol

Adverse Reaction:

Dryness of mouth and pharyneal irritation, cough, headache, dizziness, nausea, gastrointestinal distress, blurred vision, Less frequently palpitation, nervousness, drowsiness difficulty in co-ordination, constipation, rash.

Contra-Indications:

Hypersens to atropine or its cogeners. Treatment of acute episodes of bronchospasm.

Special precaution: Patients with narrow angle glaucoma, prostatic hypertrophy, pregnancy and lactation, children under 3 yrs. Bladder neck obstruction, glaucoma, or patients susceotible to glaucoma, Protect patients eyes from nebulised drug Renal and hepatic impairment Pregnancy, lactation, children

Dosages/ Overdosage Etc:

Date of Approval November 1992

Indications:

Bronchospasm with chronic obstructive pulmonary disease.

Dosage:

Usual dose: 2 inhalations(36mcg) 4 times a day. Do not exceed 12 inhalations in 24 hours.

Patient Information:

Ref - USP PDI Vol II 17th Edition (1997)

IPRATROPIUM - Inhalation

1.Allergies-

Tell your doctor if you have ever had any unusual or allergic reaction to

ipratropium, atropine, belladonna, hyoscyamine, or scopolamine, or other

inhalational aerosol medicines. Also tell your healthcare care professional

if you are allergic to soya beans, or related foods substances such as

soyabeans or peanuts.

2.Pregnancy-

Ipratropium has not been studied in pregnant women. However, it has not been

shown to cause birth defects or other problems in animal studies

3. Breast-feeding-

It is known whether ipratropium passes into breast milk. Although most medicines pass

into breast milk in small amounts,many of them may be used safely while breast-feeding.

Mothers who are taking this medicine and who wish to breast feed should discuss this

with their doctor.

4.Children-

This medicine has been tested in children, and in effective doses , has not been

shown to cause different side effects or problems than it does in adults.

5.Older adults-

Ipratropium inhalation has been tested in patients 65 years of age or older.

This medicine is not expected to cause different side effects or problems in older

people, than in adults..

6. Other medicines-

Although certain medicines should not be used together at all, in other cases two

different medicines may be used together even if an interaction might occur.

In such cases your doctor may want to change the dose, or other precautions

may be necessary.

Tell your doctor if you are using any other prescription or non-prescription

(Over-the counter) OTC medicine.

7. Other medical problems-

The presence of other medical problems may affect the use of ipratropoim .

Make sure you tell your doctor if you have any other medical problems

especially-

Difficult urination- ipratropium may make the condition worse.

Glaucoma- ipratropium may make the condition worse if it gets into the eyes

Pharmacology/ Pharmacokinetics:

Pharmacology Ipratropium for oral inhalation is a synthetic quaternary anticholinergic compound

Pharmacokinetics: Ipratropim is poorly absorbed into the systemic circulation from the nasal mucosa.

Pregnancy and lactation:

Pregnancy:

Should be used in pregnancy only if needed Nursing mothers: To be used with care

Children: Under 3 years of age- adequate data on safety and efficacy not established, but no specific contraindications reported.

Search

Look In

Keyword

Mode

	Starts With		Contains

Quick Links

Home
About Us
FAQs
Disclaimer
Site Map

Free Mobile App

About Us

FAQs

Feedback

Disclaimer: Every effort has been made to ensure that the information provided in this Database is authentic and accurate. Commissions or omissions in the database, if any, are purely inadvertent and the site owner shall not accept any liability whatsoever for any adverse consequences of any nature arising to any individual or third party, as a result of usage of this information.